Brief: Genprex Expands Clinical Trial Sites For Acclaim-3 Clinical Study Of Reqorsa Therapy In Combination With Tecentriq To Treat Small Cell Lung Cancer
03/04/2024 14:56
April 3 (Reuters) - Genprex Inc GNPX.O :
* GENPREX EXPANDS CLINICAL TRIAL SITES FOR ACCLAIM-3
CLINICAL
STUDY OF REQORSA® THERAPY IN COMBINATION WITH TECENTRIQ® TO
TREAT SMALL CELL LUNG CANCER
Source text for Eikon: ID:nPn97VSH2a
Further company coverage: GNPX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genprex
See all newsBrief: Genprex Announces Collaboration With Roche Diagnostics For Biomarker Assay Validation Studies
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Genprex Announces Ip Australia's Intent To Grant Patent For Reqorsa® Gene Therapy